RxDoctor Payments Data

Gareth Song

Gerontology · Azusa, CANPI 1356805717

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.2% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations.

$2,601in general payments, 2019–2025

Across 103 payments — averaging $25.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$455
  • Akebia Therapeutics Inc$427
  • Amgen$288
  • Fresenius USA Marketing, Inc.$284
  • Astellas Pharma US Inc$257
  • Ardelyx, Inc.$193
  • plus $698 from 14 others

What the payments were for

  • Food & beverage$2,50296%
  • Education$994%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,601 in reported general payments places this provider in the 85th percentile of 348 gerontology providers in California.

See all gerontology providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
KerendiaFinerenone49$40,684
TradjentaLinagliptin11$5,567
Sevelamer Carbonate39$5,094
LokelmaSodium Zirconium Cyclosilicate17$4,523
Calcium Acetate28$1,992
Diltiazem 12hr ErDiltiazem Hcl12$1,037
Clonidine11$958
Humalog Kwikpen U-100Insulin Lispro19$677
Famotidine32$668
Amlodipine Besylate16$278
Trazodone Hcl14$268
Sucralfate12$228
Hydralazine Hcl21$199
Potassium Chloride23$196
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen22$187

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
BayerKerendia$455$40,68449 claims
Boehringer IngelheimTradjenta$74$5,56711 claims
AstraZenecaLokelma$27$4,52317 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 348 gerontology providers in California.

Other gerontology in Azusa

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →